Novavax Soars 64% As Unknown Virus Spreads Through China

Image result for Novavax

Shares of antibiotics developer Novavax (NVAX) are soaring amid reports that a new respiratory virus has infected more than 200 people in China.

Zhong Nanshan, who leads China's National Health Commission, told China's official state-run news organization Xinhua that two cases of human-to-human transmission had been confirmed in China, one in Wuhan and one in Guangdong.

Shares of Novavax are up 64%, or $3.65, to $9.39 in premarket trading. Meanwhile, Inovio Pharmaceuticals (INO) is up 14% to $3.75 and BioCryst Pharmaceuticals (BCRX) is up 11% to $3.09.
 

Disclaimer: TheFly's news is intended for informational purposes only and does not claim to be actionable for investment decisions. Read more at  more

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.